blog re: NCCN conference - The Coach And The Critic: Stories Of Caregivers Where "Kill Me" Is Not An Option

The Coach And The Critic: Stories Of Caregivers Where "Kill Me" Is Not An Option

What Patients Value When Oncologists Give News of Cancer Recurrence: Commentary on Specific Moments in Audio-Recorded Conversations -- Back et al. 16 (3): 342 -- The Oncologist CME Online

fig 1

Note: full access after registration (free), study design used 'standardized' patients

Definitions of standardized patient:
A simulated patient or standardized patient (SP) (also known as a patient instructor), in health care, is an individual who is trained to act as a real patient in order to simulate a set of symptoms or problems. ...
en.wikipedia.org/wiki/Standardized_patient

Gastroenterology & Endoscopy News - Is Colonoscopy the Optimal Method for Colorectal Cancer Screening? (no specific mention of Lynch Syndrome

Note: no mention of Lynch Syndrome (biology/genetics), full free access with registration (free)

full free access: Research output on primary care in Australia, Canada, Germany, the Netherlands, the United Kingdom, and the United States: bibliometric analysis - bmj.com

What is already known on this topic

• The UK Research Assessment Exercise in 2008 rated 50% of UK primary care research as world class or internationally excellent, but no direct international comparisons exist

What this study adds

• In six countries with strong primary care, the United Kingdom and the Netherlands produce the most cited primary care led primary care research
• Identifying research on primary care that is carried out by primary care researchers is difficult using routine bibliometric methods
• Only 29% of research papers on primary care had at least one primary care researcher as author

Guest post: Absolute risk not as straightforward as you might think - Gary Schwitzer's HealthNewsReview Blog

"...As a Cochrane review pointed out this week (Persuasive health information could be misleading)  (note - this link forwards to a Reuters story) relative risks are very persuasive, but they don't always serve your best interests when making health decisions....:

press release/abstract: Marshall Edwards Announces Publication of Phase II Clinical Trial Results - Phenoxodiol phase 11 ovarian cancer trial results (32 pts)

SAN DIEGO, March 21, 2011 /PRNewswire/ -- Marshall Edwards, Inc.(Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer. The publication is now available on the International Journal of Gynecological Cancer website and scheduled to print in the May issue of the journal......

abstract: Int J Gynecol Cancer. 2011 Mar 15. [Epub ahead of print]

Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers.

Clinical Cancer Research Programs Merge To Accelerate Research

The American College of Radiology's Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG), National Cancer Institute (NCI) Clinical Trials Cooperative Group members, have announced their intent to merge their clinical cancer research programs.

The groups plan to form an alliance that combines their complementary strengths. The new organization will include three areas of research emphasis: early detection and diagnosis of cancer; biomarker-driven Phase II and Phase III therapeutic studies for multiple cancer types and stages; and genetic, molecular and imaging marker research to predict and monitor treatment response........cont'd

full free access: jan 2011 Cancer and Work - A Canadian Perspective Canadian Association of Psychosocial Oncology

Limited free speech for docs | Columnists | Comment | Calgary Sun

Comments

Sandi Pniauskas
    March 20th 2011, 10:16pm

    "I see no mention of the Institute for Patient Safety and their role in these issues. Aside from selected physicians (the few) who choose to speak up publicly, it's rather a continuing sad situation in Canada. For those who do speak up, healthcare professionals, patients and the public, we seem to ostracize those individuals who have the tenacity to persevere in truth telling and simply trying to do the best possible under often terrible circumstances. More so, where is the peer process in this aside from political fence sitting. There is definitely a need for both federal and provincial ombudsman positions 'with teeth'- to correct these ongoing errors of judgment."